Related Experiment Video

Updated: May 3, 2026

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
05:52

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

892

Pharmacologic neuroprotective strategies in neonatal brain injury

Sandra E Juul1, Donna M Ferriero2

  • 1Department of Pediatrics, University of Washington, 1959 Northeast Pacific Street, Box 356320, Seattle, WA 98195, USA.

Clinics in Perinatology
|February 15, 2014
PubMed

Insights

This article reviews pharmacotherapy for hypoxic-ischemic insults in newborns. Clinical trials are exploring new treatments, but optimal combination therapies require further research.

Area of Science:

  • Neonatal Medicine
  • Neuroscience
  • Pharmacology

Background:

  • Hypoxic-ischemic (HI) insults pose significant risks to both preterm and term infants.
  • Pharmacotherapy is a critical intervention for managing HI brain injury.
  • Understanding the underlying mechanisms is key to developing effective treatments.

Purpose of the Study:

  • To elucidate the mechanisms guiding pharmacotherapy selection for neonatal hypoxic-ischemic insults.
  • To review current and emerging therapeutic strategies for affected infants.
  • To highlight challenges in optimizing combination therapies.

Main Methods:

  • Review of preclinical data on pharmacologic interventions for HI brain injury.
  • Analysis of ongoing clinical trials investigating novel treatments.
  • Discussion of age- and insult-specific treatment considerations.

Main Results:

  • Preclinical evidence supports the efficacy of certain pharmacotherapies.
  • Clinical trials are actively evaluating promising treatment options.
  • Significant challenges persist in tailoring combination therapies.

Conclusions:

  • Pharmacotherapy choices for neonatal HI insults are based on evolving mechanistic understanding.
  • Advancements in preclinical research are translating into clinical investigations.
  • Personalized combination therapies are needed to address the heterogeneity of HI injury.
Keywords:
Brain injuryHypoxic-ischemic encephalopathyPreconditioningPrematurity

More Related Videos

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats07:56

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats

Published on: April 21, 2017

10.3K
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

19.2K

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
279